Reckitt Benckiser Group (RB) Given “Overweight” Rating at JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their overweight rating on shares of Reckitt Benckiser Group (LON:RB) in a report issued on Wednesday morning. They currently have a GBX 7,500 ($101.71) target price on the stock.

A number of other analysts also recently issued reports on RB. Jefferies Group dropped their price objective on shares of Reckitt Benckiser Group from GBX 8,150 ($110.52) to GBX 7,500 ($101.71) and set a hold rating for the company in a report on Friday, September 15th. Goldman Sachs Group dropped their price objective on shares of Reckitt Benckiser Group from GBX 8,130 ($110.25) to GBX 7,920 ($107.40) and set a neutral rating for the company in a report on Thursday, September 21st. Morgan Stanley reaffirmed an overweight rating and set a £100 ($135.61) price objective on shares of Reckitt Benckiser Group in a report on Thursday, September 21st. Berenberg Bank reaffirmed a buy rating and set a GBX 8,500 ($115.27) price objective on shares of Reckitt Benckiser Group in a report on Thursday, September 28th. Finally, Liberum Capital reaffirmed a buy rating and set a GBX 8,700 ($117.98) price objective on shares of Reckitt Benckiser Group in a report on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have issued a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of GBX 7,664.55 ($103.94).

Reckitt Benckiser Group (RB) traded up GBX 14 ($0.19) during midday trading on Wednesday, hitting GBX 6,800 ($92.22). 1,537,516 shares of the stock were exchanged, compared to its average volume of 1,260,000. Reckitt Benckiser Group has a 52 week low of GBX 6,299 ($85.42) and a 52 week high of GBX 8,110.43 ($109.99). The company has a market cap of $47,710.00 and a P/E ratio of 2,274.25.

In other news, insider Adrian Nevil Hennah acquired 2,285 shares of the stock in a transaction dated Wednesday, November 8th. The stock was purchased at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair acquired 2,800 shares of the stock in a transaction dated Wednesday, November 1st. The shares were purchased at an average cost of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34).

COPYRIGHT VIOLATION WARNING: “Reckitt Benckiser Group (RB) Given “Overweight” Rating at JPMorgan Chase & Co.” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/11/reckitt-benckiser-group-rb-given-overweight-rating-at-jpmorgan-chase-co.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply